Autism Spectrum Disorder Therapeutics Market

<strong>Autism</strong> <strong>Spectrum</strong> <strong>Disorder</strong> <strong>Therapeutics</strong><br />

<strong>Market</strong><br />

GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND<br />

OPPORTUNITY ANALYSIS, 2018-2026


REPORT DESCRIPTION<br />

<strong>Autism</strong> <strong>Spectrum</strong> <strong>Disorder</strong> <strong>Therapeutics</strong> <strong>Market</strong> – Overview<br />

<strong>Autism</strong> <strong>Spectrum</strong> <strong>Disorder</strong> (ASD) is a neurodegenerative disorder, which is associated and often overlaps<br />

with other conditions such as epilepsy, frequent infections, sleep disorders, anxiety, depression, and<br />

gastrointestinal problems. ASD is only diagnosed by developmental and comprehensive tests. It can be<br />

detected at eighteen months to two years of age. Drugs such as Aripiprazole, Risperidone, and Melatonin<br />

are U.S. Food and Drug Administration (FDA) approved drugs that aid in the treatment of ASD.<br />

Bumetanide and Balovaptan are the drugs that are under clinical trial and investigation to evaluate their<br />

safety and efficacy for the treatment of ASD.<br />

The global autism spectrum disorder therapeutics (ASD) therapeutics market size was valued at US$<br />

2,169.3 million in 2018, and is expected to witness a CAGR of 6.8% over the forecast period (2018 –<br />

2026).


REPORT DESCRIPTION<br />

<strong>Autism</strong> <strong>Spectrum</strong> <strong>Disorder</strong> <strong>Therapeutics</strong> <strong>Market</strong> – Dynamics<br />

Increasing prevalence of ASD worldwide is expected to boost the <strong>Autism</strong> <strong>Spectrum</strong> <strong>Disorder</strong> <strong>Therapeutics</strong><br />

(ASD) therapeutics market growth. For instance, according to the data published in Our World in Data in<br />

2017, around 62 million people worldwide were estimated to have ASD in 2016. Moreover, under 50<br />

million of these cases were found in males. Of this 62 million with ASD, around 18 million had only<br />

<strong>Autism</strong> and 44 million had Asperger syndrome and other spectrum disorders.<br />

However, stringent regulations and continuous watch employed by governing authorities for product<br />

approval and marketing of medicines can act as a potential hindrance for growth of the autism spectrum<br />

disorder therapeutics market. For instance, in May 2017, the U.S. Food and Drug Administration (FDA)<br />

shut down operations of Louisiana-based Pick and Pay Inc. / Cili Minerals, a manufacturer of drug and<br />

dietary supplements, after finding that the company was falsely marketing products as being able to treat<br />

autism.<br />

Download PDF Brochure @<br />

https://www.coherentmarketinsights.com/insight/request-pdf/2643


REPORT DESCRIPTION<br />

<strong>Autism</strong> <strong>Spectrum</strong> <strong>Disorder</strong> <strong>Therapeutics</strong> <strong>Market</strong> – Key Players<br />

• F. Hoffmann-La Roche AG<br />

• Neurim Pharmaceuticals, Inc.<br />

• Yamo Pharmaceuticals LLC<br />

• Servier Laboratories Ltd.<br />

• Otsuka Holdings Co. Ltd.<br />

• Curemark LLC<br />

• Oryzon Genomics S.A.<br />

• GW Pharmaceuticals Plc.<br />

• Teva Pharmaceutical Industries<br />

Read More @<br />

https://www.coherentmarketinsights.com/market-insight/autism-spectrum-disorder-therapeutics-market-2643


ABOUT COHERENT MARKET INSIGHTS<br />

ABOUT US<br />

Coherent <strong>Market</strong> Insights is a global market intelligence and consulting organization focused on assisting its<br />

plethora of clients achieve transformational growth by helping them make critical business decisions. We are<br />

headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players<br />

from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help<br />

businesses around the globe deliver practical and lasting results through various recommendations about<br />

operational improvements, technologies, emerging market trends and new working methods. We offer both<br />

customized and syndicated market research reports that help our clients create visionary growth plans to<br />

provide traction to their business. We meticulously study emerging trends across various industries at both the<br />

global and regional levels to identify new opportunities for our clientele.<br />

SERVICES<br />

INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH<br />

MARKET INTELLIGENCE SERVICES<br />

CONSULT STUDIES<br />

COUNTRY SPECIFIC STUDIES


ABOUT CMI<br />

SECTOR<br />

COVERAGE<br />

BIOTECHNOLOGY<br />

CLINICAL<br />

DIAGNOSTIC<br />

HEALTHCARE IT<br />

MEDICAL DEVICES<br />

MEDICAL IMAGING<br />

PHARMACEUTICAL<br />

Global Leading Equipment and System Manufacturers<br />

Component Providers and System Integrators<br />

Distributors, Retailors and Value Added Resellers<br />

Healthcare IT Solutions Developers<br />

<strong>Market</strong>ing Consultancies and the Advertising Industry<br />

Private and Government organization<br />

Outsourcing Companies<br />

Universities and Business Schools.


ABOUT US<br />

KEY STATS<br />

100<br />

+<br />

150+<br />

Insights Published Per Year<br />

Consulting Projects Till<br />

Date<br />

125+<br />

Clients Worldwide Per Year<br />

110+<br />

Analysts and Contract<br />

Consultants<br />

RESEARCH<br />

SOLUTIONS<br />

CONSULT<br />

PROJECTS<br />

SURVEY<br />

RESEARCH<br />

FEASIBILITY<br />

STUDIES<br />

EXCEL<br />

FORECAST<br />

DATABASE<br />

GLOBAL<br />

REPORTS<br />

TECHNOLOGY<br />

SNIPPETS<br />

COUNTRY<br />

ANALYSIS<br />

COMPETITIVE<br />

ASSESSMENT<br />

Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including<br />

chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />

the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />

industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />

designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />

markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.


THANK YOU<br />

To know more about us, visit our website:<br />

www.coherentmarketinsights.com<br />

For sales queries or new topics email us on:<br />

sales@coherentmarketinsights.com<br />

For other queries contact:<br />

Mr. Shah<br />

(Manager - Business Development)<br />

Coherent <strong>Market</strong> Insights<br />

sales@coherentmarketinsights.com<br />

+1-206-701-6702

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!